Lilopristone
Alternative Names: ZK 98734Latest Information Update: 12 Feb 2015
At a glance
- Originator Bayer Schering Pharma
- Class Abortifacients; Antineoplastics; Antiprogestogens; Estrenes
- Mechanism of Action Glucocorticoid receptor antagonists; Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Induced abortion; Pregnancy
Most Recent Events
- 12 Feb 2015 Discontinued - Clinical-Phase-Unknown for Induced abortion in USA (unspecified route) prior to February 2015
- 12 Feb 2015 Discontinued - Preclinical for Pregnancy (Prevention) in India (unspecified route) prior to February 2015
- 14 Aug 2001 No-Development-Reported for Induced abortion in USA (Unknown route)